Psychiatry


Omega-3 in depression

  • 11/09/2016

Major depressive disorder (MDD) is associated with high morbidity and mortality and a substantial reduction in quality of life.

Read more



Omega-3 could reduce cardiovascular mortality in schizophrenia

  • 08/31/2016

There is an inflammatory process common to the symptoms of schizophrenia, arterial elasticity and cardiovascular disease (CVD). This leads to the following observations:

Read more



DHA in cognition in maturity and ageing

  • 06/15/2016

The fact that cognitive function peaks in adulthood means that the effects of consuming docosahexaenoic acid (DHA) must be assessed over long time periods, to cover possible variability.

Read more



EPA and DHA in cognitive impairment, emotional dysfunction and cerebral atrophy

  • 04/18/2016

Age-related cognitive impairment is characterised by progressive and irreversible loss of grey matter in various regions of the brain, together with atrophy of the hippocampus and the prefrontal

Read more



Supplementation in psychiatric practice

  • 03/23/2016

Epidemiological studies have observed an inverse correlation between per capita fish consumption and the prevalence of major depression, postnatal depression and bipolar spectrum disorders.

Read more



EPA and depression associated with inflammation

  • 01/15/2016

Despite advances in neuroscience, treatment of major depressive disorder remains a challenge, as current pharmacological treatments often fail to cover clinical needs.

Read more



DHA counteracts age-associated cognitive deterioration and is beneficial in the prevention of Alzheimer’s disease

  • 12/21/2012

Alzheimer's disease requires therapeutic and preventative measures due to its high incidence worldwide. Before the final stage of the disease, there is a progression period during which action may be taken.

Read more



Beneficial effects on Alzheimer’s disease of long-chain omega-3 fatty acids (EPA and DHA) at high concentrations

  • 01/07/2013

Alzheimer's disease is the main cause of dementia among the elderly. At its genesis, two anomalous structures appear in the brain, plaques and neurofibrillary tangles, which contribute to the characteristic deterioration of nerve cells associated with the disease.

Read more



Consumption of fatty acid-rich fish improves paroxetine response

  • 03/26/2015

Up to 50% of patients with major depressive disorder (MDD) do not respond to treatment with selective serotonin re-uptake inhibitors (SSRIs).

Read more



EPA/DHA supplementation could permit a reduction to the methylphenidate dose

  • 04/24/2015

Attention deficit hyperactivity disorder (ADHD) is normally treated with stimulants, such as methylphenidate, due to their clinical efficacy.

Read more


Pages